Cite

HARVARD Citation

    Xu, S. et al. (2020). A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma. Clinical and translational medicine. 10 (5), p. n/a. [Online]. 
  
Back to record